US Stock MarketDetailed Quotes

QNCX Quince Therapeutics

Watchlist
  • 1.050
  • -0.010-0.94%
Trading Apr 23 10:25 ET
45.38MMarket Cap-1250P/E (TTM)

Quince Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-46.98%27.14M
32.03%8.34M
-10.32%6.09M
-65.65%5.58M
-67.73%7.06M
-43.32%51.19M
-73.16%6.32M
-68.65%6.8M
-25.36%16.26M
-6.22%21.86M
Selling and administrative expenses
-31.97%17.7M
38.24%4.91M
7.34%4.66M
-53.30%4.23M
-57.98%3.83M
-11.89%26.01M
-57.38%3.55M
-43.13%4.34M
28.24%9.06M
40.33%9.11M
-General and administrative expense
-31.97%17.7M
38.24%4.91M
7.34%4.66M
-53.30%4.23M
-57.98%3.83M
-11.89%26.01M
-57.38%3.55M
-43.13%4.34M
28.24%9.06M
40.33%9.11M
Research and development costs
-62.48%9.45M
24.06%3.43M
-41.62%1.43M
-81.21%1.35M
-74.68%3.23M
-58.59%25.18M
-81.81%2.77M
-82.54%2.45M
-51.09%7.2M
-24.17%12.76M
Operating profit
46.98%-27.14M
-32.03%-8.34M
10.32%-6.09M
65.65%-5.58M
67.73%-7.06M
43.32%-51.19M
73.16%-6.32M
68.65%-6.8M
25.36%-16.26M
6.22%-21.86M
Net non-operating interest income expense
225.66%3.48M
89.18%1.01M
204.44%959K
455.17%805K
872.22%700K
72.26%1.07M
410.48%536K
146.09%315K
-9.38%145K
-68.28%72K
Non-operating interest income
225.66%3.48M
89.18%1.01M
204.44%959K
455.17%805K
872.22%700K
72.26%1.07M
410.48%536K
146.09%315K
-9.38%145K
-68.28%72K
Other net income (expense)
-334.58%-7.92M
-708.03%-1.51M
85.01%-216K
85.44%-107K
-4,197.33%-6.15M
-637.65%-1.82M
522.50%249K
-817.83%-1.44M
-461.07%-735K
150K
Special income (charges)
-806.42%-7.48M
---1.58M
--0
--0
---5.9M
---825K
--0
---825K
--0
--0
-Less：Restructuring and merger&acquisition
--1.58M
----
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
615.15%5.9M
--0
--0
--0
--5.9M
--825K
--0
--825K
--0
--0
Other non- operating income (expenses)
55.87%-440K
-74.30%64K
64.94%-216K
85.44%-107K
-264.00%-246K
-303.64%-997K
522.50%249K
-292.36%-616K
-461.07%-735K
--150K
Income before tax
39.20%-31.58M
-59.79%-8.84M
32.45%-5.35M
71.00%-4.89M
42.23%-12.5M
42.25%-51.94M
76.35%-5.53M
63.51%-7.92M
22.55%-16.85M
6.26%-21.64M
Income tax
30.63%-197K
51K
0
0
-248K
-284K
0
0
-284K
0
Net income
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
23.86%-16.56M
6.26%-21.64M
Net income continuous Operations
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
23.86%-16.56M
6.26%-21.64M
Minority interest income
Net income attributable to the parent company
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
23.86%-16.56M
6.26%-21.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
23.86%-16.56M
6.26%-21.64M
Basic earnings per share
45.45%-0.84
-61.54%-0.21
31.82%-0.15
72.55%-0.14
52.78%-0.34
49.17%-1.54
83.33%-0.13
69.86%-0.22
31.08%-0.51
7.69%-0.72
Diluted earnings per share
45.45%-0.84
-61.54%-0.21
31.82%-0.15
72.55%-0.14
52.78%-0.34
49.17%-1.54
83.33%-0.13
69.86%-0.22
31.08%-0.51
7.69%-0.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -46.98%27.14M32.03%8.34M-10.32%6.09M-65.65%5.58M-67.73%7.06M-43.32%51.19M-73.16%6.32M-68.65%6.8M-25.36%16.26M-6.22%21.86M
Selling and administrative expenses -31.97%17.7M38.24%4.91M7.34%4.66M-53.30%4.23M-57.98%3.83M-11.89%26.01M-57.38%3.55M-43.13%4.34M28.24%9.06M40.33%9.11M
-General and administrative expense -31.97%17.7M38.24%4.91M7.34%4.66M-53.30%4.23M-57.98%3.83M-11.89%26.01M-57.38%3.55M-43.13%4.34M28.24%9.06M40.33%9.11M
Research and development costs -62.48%9.45M24.06%3.43M-41.62%1.43M-81.21%1.35M-74.68%3.23M-58.59%25.18M-81.81%2.77M-82.54%2.45M-51.09%7.2M-24.17%12.76M
Operating profit 46.98%-27.14M-32.03%-8.34M10.32%-6.09M65.65%-5.58M67.73%-7.06M43.32%-51.19M73.16%-6.32M68.65%-6.8M25.36%-16.26M6.22%-21.86M
Net non-operating interest income expense 225.66%3.48M89.18%1.01M204.44%959K455.17%805K872.22%700K72.26%1.07M410.48%536K146.09%315K-9.38%145K-68.28%72K
Non-operating interest income 225.66%3.48M89.18%1.01M204.44%959K455.17%805K872.22%700K72.26%1.07M410.48%536K146.09%315K-9.38%145K-68.28%72K
Other net income (expense) -334.58%-7.92M-708.03%-1.51M85.01%-216K85.44%-107K-4,197.33%-6.15M-637.65%-1.82M522.50%249K-817.83%-1.44M-461.07%-735K150K
Special income (charges) -806.42%-7.48M---1.58M--0--0---5.9M---825K--0---825K--0--0
-Less：Restructuring and merger&acquisition --1.58M------------------0----------------
-Less:Impairment of capital assets 615.15%5.9M--0--0--0--5.9M--825K--0--825K--0--0
Other non- operating income (expenses) 55.87%-440K-74.30%64K64.94%-216K85.44%-107K-264.00%-246K-303.64%-997K522.50%249K-292.36%-616K-461.07%-735K--150K
Income before tax 39.20%-31.58M-59.79%-8.84M32.45%-5.35M71.00%-4.89M42.23%-12.5M42.25%-51.94M76.35%-5.53M63.51%-7.92M22.55%-16.85M6.26%-21.64M
Income tax 30.63%-197K51K00-248K-284K00-284K0
Net income 39.25%-31.39M-60.72%-8.89M32.45%-5.35M70.50%-4.89M43.38%-12.25M42.56%-51.66M76.35%-5.53M63.51%-7.92M23.86%-16.56M6.26%-21.64M
Net income continuous Operations 39.25%-31.39M-60.72%-8.89M32.45%-5.35M70.50%-4.89M43.38%-12.25M42.56%-51.66M76.35%-5.53M63.51%-7.92M23.86%-16.56M6.26%-21.64M
Minority interest income
Net income attributable to the parent company 39.25%-31.39M-60.72%-8.89M32.45%-5.35M70.50%-4.89M43.38%-12.25M42.56%-51.66M76.35%-5.53M63.51%-7.92M23.86%-16.56M6.26%-21.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 39.25%-31.39M-60.72%-8.89M32.45%-5.35M70.50%-4.89M43.38%-12.25M42.56%-51.66M76.35%-5.53M63.51%-7.92M23.86%-16.56M6.26%-21.64M
Basic earnings per share 45.45%-0.84-61.54%-0.2131.82%-0.1572.55%-0.1452.78%-0.3449.17%-1.5483.33%-0.1369.86%-0.2231.08%-0.517.69%-0.72
Diluted earnings per share 45.45%-0.84-61.54%-0.2131.82%-0.1572.55%-0.1452.78%-0.3449.17%-1.5483.33%-0.1369.86%-0.2231.08%-0.517.69%-0.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg